{'fraction_non_alphanumeric': 0.03782894736842105, 'fraction_numerical': 0.027960526315789474, 'mean_word_length': 5.305699481865285, 'pattern_counts': {'":': 0, '<': 0, '<?xml version=': 0, '>': 0, 'https://': 0, 'lorem ipsum': 0, 'www.': 0, 'xml': 0}, 'pii_count': 0, 'substrings_counts': 0, 'word_list_counts': {'cursed_substrings.json': 0, 'profanity_word_list.json': 0, 'sexual_word_list.json': 0, 'zh_pornsignals.json': 0}}
Cyanidin-3-O-glucoside protects lens epithelial cells against high glucose induced apoptosis and prevents cataract formation via suppressing NF-κB activation and Cox-2 expression.

Diabetic cataract is one of the most important causes of blindness worldwide. Cyanidin-3-O-glucoside (C3G) is found to exert beneficial effect on many diabetic complications. However, its effect on diabetic cataract is not well known. Herein, we investigated the effect of C3G on high glucose-induced lens epithelial cells (SRA01/04) apoptosis and cataract formation as well as the involved mechanisms. We found C3G (20 μM) could preserve cell viability in SRA01/04 cells exposed to high glucose (100 μM). Meanwhile, C3G inhibited SRA01/04 cells apoptosis and regulated Bcl-2/Bax ratio. Additionally, C3G suppressed NF-κB activation and subsequent Cyclooxygenases-2 (Cox-2) expression, which are associated with the protection against apoptosis. Moreover, C3G attenuated lens opacity and proteins aggregation in lens culture exposed to high glucose. In conclusion, C3G protected against high glucose induced SRA01/04 cells apoptosis and cataract formation, which indicated the potential protection of anthocyanins on diabetic cataract.